The inclusion of Melasyl — L'Oréal's patented molecule born from screening 100,000 candidates over 18 years — sets this apart from every other brightening serum on the market. While most dark spot correctors rely solely on tyrosinase inhibition, this formula intercepts melanin formation at a later, previously untargeted stage. Combined with niacinamide, tranexamic acid, glycolic acid, and vitamin C, it attacks hyperpigmentation through five distinct biochemical pathways.
A genuinely innovative brightening serum that earns its place through L'Oréal's proprietary Melasyl molecule — something no competitor can replicate — combined with a five-pathway approach to hyperpigmentation that delivers visible results within a month. At $45, it punches well above typical pharmacy-brand pricing but justifies it with pharmaceutical-grade research depth.
This serum was reformulated with Melasyl in 2024. While the original 2022 version has a longer track record, the current formula has approximately 500-800 user reviews across retailers. Our scoring reflects both ingredient analysis and growing real-world feedback on the updated formulation. We'll revisit this review as more data accumulates on the Melasyl version.
The case for it
Cautions: a photosensitising active — use sun protection.
Same rule for everyone. “Good choice” is the verdict on 9,564 of 45,024 concern verdicts across the catalog; rule R5 decided 9,072 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
Cautions: a photosensitising active — use sun protection.
What would change this: Guideline or regulatory standing for the active on this concern would move this from a promising bet to a recommendation.
Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
Cautions: a photosensitising active — use sun protection.
What would change this: Guideline or regulatory standing for the active on this concern would move this from a promising bet to a recommendation.
Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
What would change this: A concentration inside the studied range would raise this a step.
Same rule for everyone. “Supporting role” is the verdict on 8,197 of 45,024 concern verdicts across the catalog; rule R7 decided 258 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
Cautions: a photosensitising active — use sun protection.
What would change this: Guideline or regulatory standing for the active on this concern would move this from a promising bet to a recommendation.
Same rule for everyone. “Promising” is the verdict on 7,858 of 45,024 concern verdicts across the catalog; rule R9p decided 7,858 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
The case for it
What would change this: A concentration inside the studied range would raise this a step.
Same rule for everyone. “Supporting role” is the verdict on 8,197 of 45,024 concern verdicts across the catalog; rule R7 decided 258 of them. Unchanged since September 5, 2026, engine 5.1.1.
Brand or formulator? Disclose a concentration or correct a fact →
The studies behind the evidence row
Where our review and the verdict differ. The review below was written on the formulation and the published trials; the verdicts above apply the stricter standing test in our methodology — an active earns a recommendation only with guideline or regulatory standing for the concern. Where the two disagree, the verdict is DermApproved’s position.
A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide
Most dark spot serums are variations on a theme: take a tyrosinase inhibitor, add some niacinamide, sprinkle in vitamin C, and call it innovation. Vichy's LiftActiv B3 does something genuinely different, and the story behind it matters. L'Oréal's research team spent 18 years — the kind of timeline usually reserved for pharmaceutical drug development — screening 100,000 molecules to find one that could intercept melanin formation at a stage no cosmetic ingredient had previously targeted. That molecule is Melasyl, and this serum is its flagship vehicle.
The science is worth understanding because it explains why this product works differently than everything else in your medicine cabinet. Traditional brightening ingredients — hydroquinone, arbutin, kojic acid — work by inhibiting tyrosinase, the enzyme that kicks off melanin production. Melasyl ignores tyrosinase entirely. Instead, it captures dopaquinone, DHI, and DHICA — the intermediate compounds that form after tyrosinase has done its work but before they polymerize into the visible pigment you see as a dark spot. It is, essentially, an interceptor operating at a checkpoint that other ingredients do not address. That mechanism is also the answer to a common fear about dark-spot products — that they 'bleach' the skin. This one bleaches nothing. Melasyl catches pigment precursors, niacinamide blocks pigment from transferring to surface cells, and glycolic acid speeds the removal of cells that are already pigmented. It's interception and turnover, not bleaching.
But Vichy did not build a one-trick formula. The 8% niacinamide blocks melanosome transfer — preventing the melanin that does form from reaching the skin's surface cells. Tranexamic acid quiets the inflammatory signals that trigger overproduction in the first place. Glycolic acid at roughly 1.5% accelerates the shedding of cells that are already pigmented. Ascorbyl glucoside provides antioxidant coverage and mild tyrosinase inhibition. That is five distinct mechanisms working on the same problem from different angles, and it is the kind of multi-pathway formulation strategy that dermatologists have been advocating for years. It's also a quiet rebuttal to the old warning that niacinamide and vitamin C cancel each other out — that instability only ever applied to pure L-ascorbic acid under heat, and the stable ascorbyl glucoside here sits alongside niacinamide with no efficacy trade-off at all.
The texture is almost startlingly lightweight — more reminiscent of a watery essence than a traditional serum. It disappears into skin within seconds, leaving nothing tacky, nothing filmy, just skin that feels marginally smoother. The precision dose applicator, a burgundy glass bottle that you flip and squeeze, is more clinical than elegant. Some users find the dispensing mechanism fiddly, requiring a twist-and-squeeze motion that lacks the satisfying click of a standard dropper. It is a minor ergonomic annoyance in an otherwise well-considered product.
Fragrance-free is the right call for a product targeting hyperpigmentation — the population dealing with dark spots skews toward post-inflammatory sensitivity, melasma sufferers, and post-procedure skin, none of whom need added irritants. The inclusion of dipotassium glycyrrhizate and allantoin as soothing agents shows formulation thoughtfulness. These ingredients are not decoration. They actively buffer the glycolic acid, keeping the formula accessible to sensitive skin types who would otherwise need to avoid chemical exfoliants. In practice you apply three to five drops after cleansing and toning, before heavier serums and moisturizer, and — because the glycolic acid raises photosensitivity — sunscreen every morning is non-negotiable.
Real-world performance aligns with the clinical data, though with appropriate caveats. Surface-level sunspots and post-acne marks respond well within four to six weeks, with early general brightening often visible in the first week or two and deeper, more stubborn pigmentation continuing to improve out to the eight-to-twelve-week mark. Users consistently report that hard-to-define radiance improvement even before individual spots fade, and the formula excels at preventing new spots from darkening, which is arguably more valuable than treating existing ones. Where it falls short is deep, hormonal melasma. If your hyperpigmentation is driven by hormonal fluctuations rather than UV damage, this serum will help at the margins but will not replace prescription-strength interventions.
At $45 for one ounce, this is premium pharmacy-brand territory — well above the mass-market drugstore price bracket but below the luxury tier. The price reflects 18 years of Melasyl development and a genuine intellectual property advantage. You are not paying for fragrance, packaging theater, or a celebrity endorsement. You are paying for a molecule that literally does something nothing else on the market can do. Whether that premium is worth it depends on how stubborn your dark spots are. For sunspots and post-inflammatory marks, this is one of the most scientifically credible options under $50, and its reception reflects that — across a moderate review base averaging solidly, users report visibly faded spots within four to eight weeks and a lightweight non-sticky feel gentle enough for sensitive skin, while the recurring caveats are the fiddly applicator, the need for a follow-up moisturizer, and limited results on deep hormonal melasma.
The 30 mL bottle lasts roughly two to three months at the recommended three-to-five drops twice daily, which brings the effective monthly cost to around $15-22. That is reasonable for a targeted treatment serum, and the absence of alternative sizes means you are locked into the standard bottle. One note on housekeeping: the formula isn't fungal-acne-safe, so malassezia-prone users should factor that in.
Vichy's nine decades of pharmacy-brand credibility and L'Oréal's research infrastructure lend this product a level of scientific backing that most competitors cannot match. It's not a serum that went viral on TikTok and then scrambled to justify its claims. It is a serum that spent nearly two decades in development, went through 121 studies, and arrived on shelves with its homework already done.
The hero actives that drive this product's performance.
| Ingredient | Function | Evidence |
|---|---|---|
| Niacinamide (Vitamin B3) (8%) | Serves as the backbone of this multi-target brightening formula, inhibiting melanosome transfer from melanocytes to keratinocytes while reinforcing the skin barrier alongside the glycerin and allantoin in the formula. At 8%, it also helps regulate sebum and reduce the inflammation that can worsen post-inflammatory hyperpigmentation. | Emerging for Hyperpigmentation |
| Melasyl (2-Mercaptonicotinoyl Glycine) (0.5%) | L'Oréal's patented molecule — the result of screening 100,000 candidates over 18 years — that captures melanin precursors (dopaquinone, DHI, DHICA) before they polymerize into visible pigment. Works downstream of tyrosinase, complementing the niacinamide and tranexamic acid in this formula which act at earlier stages of the pigmentation cascade. | Not yet assessed |
| Tranexamic Acid (~1.4%) | Reduces UV-induced and inflammation-driven melanin production by blocking the plasminogen pathway, addressing the inflammatory triggers that the niacinamide and Melasyl in this formula don't directly target. Particularly effective for post-inflammatory hyperpigmentation and melasma-adjacent discoloration. | Limited for Hyperpigmentation |
| Glycolic Acid (~1.5%) | Provides gentle chemical exfoliation to accelerate turnover of pigmented surface cells, ensuring that the new, more evenly pigmented skin revealed by the Melasyl and niacinamide becomes visible faster. At this low concentration, it aids penetration of other actives without causing significant irritation. | Established mechanism for Rough Texture · established mechanism |
| Ascorbyl Glucoside | A stable vitamin C derivative that provides antioxidant protection against UV-generated free radicals while offering mild tyrosinase inhibition — adding yet another layer to this formula's multi-pathway approach to pigmentation control. | Limited for Hyperpigmentation |
| Dipotassium Glycyrrhizate | Licorice-derived anti-inflammatory that calms the skin's reactive response to the glycolic acid in the formula while contributing its own mild brightening effect through tyrosinase inhibition. | Limited for Hyperpigmentation |
Ingredient standings describe the active at treatment-level doses and vehicles; this product's own condition grades weigh its actual formula.
Aqua/Water/Eau, Niacinamide, Butylene Glycol, Hydroxyethylpiperazine Ethane Sulfonic Acid, Glycerin, Pentylene Glycol, Propanediol, Hydroxyethyl Urea, Glycolic Acid, Arginine, Tranexamic Acid, Hydrolyzed Rice Protein, Allantoin, Citric Acid, Cystoseira Tamariscifolia Extract, Sodium Hydroxide, Trisodium Ethylenediamine Disuccinate, 2-Mercaptonicotinoyl Glycine, Ascorbyl Glucoside, Dipotassium Glycyrrhizate, Caprylyl Glycol, Xanthan Gum, CI 16035/Red 40
serum
AM & PM
Apply 3-5 drops after cleansing and toning, before heavier serums and moisturizer. Always follow with SPF in the morning — glycolic acid increases photosensitivity.
Initial brightening and improved radiance within 1-2 weeks. Visible fading of surface-level dark spots at 4-6 weeks. Deeper hyperpigmentation and more stubborn spots show improvement at 8-12 weeks with consistent twice-daily use.
The standout ingredient here is Melasyl (2-Mercaptonicotinoyl Glycine), a molecule L'Oréal developed through a screening program that evaluated 100,000 candidates before narrowing to 23, then selecting one. Melasyl's mechanism is distinct from any other cosmetic brightening agent: it captures melanin precursors — specifically dopaquinone, DHI (5,6-dihydroxyindole), and DHICA (5,6-dihydroxyindole-2-carboxylic acid) — before they polymerize into eumelanin or pheomelanin. In vivo studies conducted by L'Oréal Research demonstrated that topical Melasyl application prevented UV-induced skin darkening and delayed tanning, confirming activity at the precursor interception stage rather than through tyrosinase inhibition.
The niacinamide component operates through a well-established mechanism. A landmark study by Hakozaki et al. published in the British Journal of Dermatology (2002) demonstrated that 5% niacinamide significantly reduced hyperpigmentation and inhibited melanosome transfer from melanocytes to keratinocytes in a double-blind, randomized trial. This serum uses 8%, exceeding the clinically validated threshold.
Translating the tranexamic acid evidence to topical application, Shin et al. published a randomized, double-blind, vehicle-controlled trial in 2013 (Skin Research and Technology) showing that a topical combination of niacinamide and tranexamic acid significantly reduced melanin index scores in 42 subjects at 4 and 8 weeks. This is directly relevant to the B3 serum's formulation, which pairs both ingredients.
The glycolic acid at approximately 1.5% serves a dual purpose: accelerating desquamation of pigmented corneocytes and enhancing penetration of the other actives. At this concentration, it falls below the irritation threshold established in clinical literature while still providing meaningful exfoliation — a formulation choice that prioritizes long-term compliance over aggressive single-use results.
Dermatologists frequently recommend multi-target approaches to hyperpigmentation, and this formula aligns with that clinical philosophy. A widely shared clinical view is that combining ingredients that work at different stages of the melanin pathway — tyrosinase inhibition, melanosome transfer blockade, precursor interception, and accelerated cell turnover — produces superior outcomes compared to single-agent treatments. The inclusion of tranexamic acid is particularly valued in dermatological practice for its anti-inflammatory properties, which address the underlying triggers of post-inflammatory hyperpigmentation. Dermatologists commonly advise patients that topical brightening treatments require 8-12 weeks of consistent use to evaluate efficacy, and that daily broad-spectrum sunscreen is non-negotiable during treatment. This product is frequently recommended as a maintenance treatment following in-office procedures such as chemical peels or laser therapy for pigmentation.
Apply 3-5 drops to clean, dry skin morning and evening. Turn the precision dose applicator upside down and gently squeeze the base to dispense. Spread evenly across the face and neck, focusing on areas of discoloration. Allow to absorb for 30-60 seconds before layering moisturizer. In the morning, always follow with broad-spectrum SPF 30 or higher — the glycolic acid in this formula increases photosensitivity, and UV protection is essential when treating hyperpigmentation. Can be layered under hyaluronic acid serums if additional hydration is needed.
At $45 for 30 mL, this serum sits at the upper end of pharmacy-brand pricing but remains well below luxury and clinical brands charging $80-150 for comparable targeted serums. The cost is justified by the proprietary Melasyl molecule — an ingredient exclusive to L'Oréal brands that represents genuine intellectual property, not just marketing differentiation. The bottle lasts approximately 2-3 months, bringing the monthly cost to roughly $15-22. No larger economy size is available. For a serum backed by 18 years of dedicated research and featuring a patented active unavailable elsewhere, the price-to-innovation ratio is strong. Vichy's legacy as a French pharmacy brand with nine decades of dermatological credibility adds further weight to the value proposition.
Anyone dealing with sunspots, post-inflammatory hyperpigmentation, or general skin dullness who wants a scientifically rigorous, multi-pathway approach to brightening. Ideal for those who want pharmacy-brand reliability with a genuine innovation advantage that no competitor currently offers.
Those with deep hormonal melasma should manage expectations — this helps at the margins but won't replace prescription treatments. Anyone with very reactive skin who cannot tolerate even low-concentration glycolic acid should patch test carefully or look for AHA-free alternatives.
Ready to try Vichy LiftActiv B3 Dark Spot Serum?
Buy at Amazon ♥Lightweight, watery-gel serum that feels almost like a refined toner. Spreads easily and absorbs within seconds, leaving no sticky or tacky residue.
Fragrance-free with virtually no detectable scent.
Dark burgundy glass bottle with a precision dose applicator. The dropper mechanism requires turning the applicator upside down and gently squeezing the base — clinical and sleek, though the dispensing action takes some getting used to.
Most users notice an immediate subtle brightening and smoother texture within the first few applications. No significant tingling or adjustment period for most skin types, though those sensitive to glycolic acid may experience mild warmth initially. True dark spot fading begins around week 3-4.
2-3 months applied morning and evening facial application at 3-5 drops per use
All Year
Vichy launched the original B3 serum in 2022 as a niacinamide-forward dark spot treatment. In 2024, it was reformulated to include Melasyl, the culmination of L'Oréal's 18-year, 121-study research program that screened 100,000 molecules to find one that could capture melanin precursors before they become visible pigment — a mechanism no other cosmetic ingredient replicates.
Vichy was founded in 1931 near the thermal springs of Vichy, France, and operates under L'Oréal's Dermatological Beauty division. The brand's formulations are developed with dermatologists and backed by clinical testing, with its Mineralizing Thermal Water featuring in peer-reviewed research.
Niacinamide and vitamin C can't be used together in the same formula
This has been debunked — the instability issue occurs only with pure L-ascorbic acid at high temperatures. This serum uses ascorbyl glucoside, a stable vitamin C derivative that coexists with niacinamide without any efficacy concerns.
Dark spot serums work by bleaching the skin
This formula doesn't bleach anything. Melasyl captures melanin precursors before they become pigment, niacinamide blocks pigment transfer, and glycolic acid accelerates removal of already-pigmented cells. It's interception, not bleaching.
Most users see initial brightening within 1-2 weeks, with visible fading of surface-level dark spots at 4-6 weeks. Deeper hyperpigmentation typically requires 8-12 weeks of consistent twice-daily use. The multi-active formula works through several pathways simultaneously, but melanin turnover takes time.
Yes, but introduce carefully. This serum contains glycolic acid, so pairing it with retinol increases exfoliation intensity. Start by alternating — B3 serum in the morning, retinol at night — and monitor for irritation before using both in the same routine.
The formula is dermatologist-tested, allergy-tested, and fragrance-free, with soothing ingredients like allantoin and dipotassium glycyrrhizate to buffer the glycolic acid. Most sensitive skin types tolerate it well, though a patch test is recommended if you're reactive to AHAs.
It can help with mild melasma and surface-level discoloration, particularly through its tranexamic acid and Melasyl content. However, deep hormonal melasma often requires prescription-strength treatments. This serum works best as a maintenance product alongside professional melasma management.
Melasyl (2-Mercaptonicotinoyl Glycine) is L'Oréal's patented molecule developed over 18 years of research. Unlike traditional brightening ingredients that inhibit tyrosinase, Melasyl captures melanin precursors — dopaquinone, DHI, and DHICA — before they polymerize into visible pigment, targeting a previously unaddressed step in melanin formation.
Absolutely. This serum contains glycolic acid, which increases photosensitivity, and you're treating hyperpigmentation — UV exposure is the primary trigger for dark spot formation. Using this serum without daily SPF 30+ would undermine its effectiveness.
Not quite. The 2024 reformulation upgraded niacinamide from 5% to 8% and added Melasyl (0.5%), L'Oréal's patented melanin-intercepting molecule, along with Cystoseira Tamariscifolia extract. The core philosophy is the same, but the current version is significantly more potent.
Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.
Visibly fades dark spots within 4-8 weeks of consistent use
Lightweight, non-sticky texture absorbs quickly without residue
Gentle enough for sensitive skin despite multiple actives
Noticeable improvement in overall skin radiance and evenness
Fragrance-free formula with no detectable scent
Precision dose applicator requires screw/unscrew motion that feels fiddly
Not hydrating enough to use without a follow-up moisturizer
Results on deep or hormonal melasma are limited
Takes 4+ weeks to see meaningful results — patience required
Verified answers from our questions library — the nuance a product page cannot carry.
